LEADER 02960nam  2200613 a 450 
001 9910456612303321
005 20200520144314.0
010   $a1-62100-439-2
035   $a(CKB)2550000000046563
035   $a(EBL)3021409
035   $a(SSID)ssj0000569772
035   $a(PQKBManifestationID)12194919
035   $a(PQKBTitleCode)TC0000569772
035   $a(PQKBWorkID)10587026
035   $a(PQKB)10578662
035   $a(MiAaPQ)EBC3021409
035   $a(Au-PeEL)EBL3021409
035   $a(CaPaEBR)ebr10683067
035   $a(OCoLC)750642412
035   $a(EXLCZ)992550000000046563
100   $a20110125d2011      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aPharmaceutical industry$b[electronic resource] $einnovation and developments /$fDavid A. Mancuso and Isobel M. Grenada, editors
210   $aHauppauge, N.Y. $cNova Science$dc2011
215   $a1 online resource (194 p.)
225 1 $aBusiness issues, competition and entrepreneurship
225 1 $aPharmacology-research, safety testing and regulation
300   $aDescription based upon print version of record.
311   $a1-61209-394-9 
320   $aIncludes bibliographical references and index.
327   $aAuthorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Authorized generics : an interim report / FTC -- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context" -- Federal R&D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht -- Pharmaceutical R&D and the evolving market for prescription drugs / CBO -- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther -- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas -- FDA's authority to regulate drug compounding : a legal analysis / Jennifer Staman -- Promotional spending for prescription drugs / CBO.
410  0$aBusiness issues, competition and entrepreneurship series.
410  0$aPharmacology-research, safety testing, and regulation series.
606   $aDrug development
606   $aPharmaceutical industry
606   $aDrugs$xLaw and legislation
608   $aElectronic books.
615  0$aDrug development.
615  0$aPharmaceutical industry.
615  0$aDrugs$xLaw and legislation.
676   $a615/.19
701   $aMancuso$b David A$0958609
701   $aGrenada$b Isobel M$0958610
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910456612303321
996   $aPharmaceutical industry$92172186
997   $aUNINA